These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18582969)

  • 1. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention.
    van Gaal WJ; Ponnuthurai FA; Selvanayagam J; Testa L; Porto I; Neubauer S; Banning AP
    Int J Cardiol; 2009 Jun; 135(1):60-5. PubMed ID: 18582969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention.
    Ng MK; Yong AS; Ho M; Shah MG; Chawantanpipat C; O'Connell R; Keech A; Kritharides L; Fearon WF
    Circ Cardiovasc Interv; 2012 Aug; 5(4):515-22. PubMed ID: 22874078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
    Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
    JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
    Farooq V; Girasis C; Magro M; Onuma Y; Morel MA; Heo JH; Garcia-Garcia H; Kappetein AP; van den Brand M; Holmes DR; Mack M; Feldman T; Colombo A; Ståhle E; James S; Carrié D; Fournial G; van Es GA; Dawkins KD; Mohr FW; Morice MC; Serruys PW
    EuroIntervention; 2013 Mar; 8(11):1277-85. PubMed ID: 23537954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.
    Valgimigli M; Serruys PW; Tsuchida K; Vaina S; Morel MA; van den Brand MJ; Colombo A; Morice MC; Dawkins K; de Bruyne B; Kornowski R; de Servi S; Guagliumi G; Jukema JW; Mohr FW; Kappetein AP; Wittebols K; Stoll HP; Boersma E; Parrinello G;
    Am J Cardiol; 2007 Apr; 99(8):1072-81. PubMed ID: 17437730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.
    van Gaal WJ; Arnold JR; Testa L; Karamitsos T; Lim CC; Ponnuthurai FA; Petersen S; Francis JM; Selvanayagam J; Sayeed R; West N; Westaby S; Neubauer S; Banning AP
    EuroIntervention; 2011 Jan; 6(6):703-10. PubMed ID: 21205592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.
    Capodanno D; Di Salvo ME; Cincotta G; Miano M; Tamburino C; Tamburino C
    Circ Cardiovasc Interv; 2009 Aug; 2(4):302-8. PubMed ID: 20031732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions.
    Singh M; Rihal CS; Lennon RJ; Garratt KN; Holmes DR
    J Am Coll Cardiol; 2004 Jul; 44(2):357-61. PubMed ID: 15261931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bifurcation lesions on angiographic characteristics and procedural success in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Frangos C; Noble S; Piazza N; Asgar A; Fortier A; Ly QH; Bonan R
    Arch Cardiovasc Dis; 2011 Apr; 104(4):234-41. PubMed ID: 21624790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study.
    Rastan AJ; Boudriot E; Falk V; Kappetein AP; Borger MA; Serruys PW; Schuler G; Mohr FW
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):376-82; discussion 382-3. PubMed ID: 18579392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Theuerle J; Yudi MB; Farouque O; Andrianopoulos N; Scott P; Ajani AE; Brennan A; Duffy SJ; Reid CM; Clark DJ;
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E227-E234. PubMed ID: 29139601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I; Samuel J; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(2):103-9. PubMed ID: 19327672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
    Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.